Close Menu

NEW YORK (GenomeWeb) – Novacyt reported today that full year 2016 revenues rose 25 percent year over year, driven in part by revenue growth from its Novaprep liquid cytology solution and by its acquisition in May 2016 of Primerdesign, a real-time PCR company.

For the full year 2016, the firm said that revenues rose to €11.1 million ($11.99 million) from €8.9 million in 2015. Revenues grew 38 percent at constant exchange rates, the company said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jun
04
Sponsored by
Ovation

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.  

Jul
15
Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.